Tom Nolan’s research review in the BMJ corrected a mistake about the classification of drugs semaglutide and liraglutide as GLP-1 receptor antagonists. The correct classification is GLP-1 receptor agonists. The correction was made to the article published on September 12, 2024.
Source link
New treatments for migraine … and other research
